Lucid Diagnostics Inc. Common Stock

LUCD XNAS • SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

170M

Short interest (Jul 15)

5.7%

Net Short (Jul 27 ): 0.1%

Borrow Fee

0.65%

Available Shares

Price Chart

Company Overview

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Company Info

Exchange: NASDAQ

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

CIK: 0001799011

Asset Type: CS

Market Data

Market Cap: $173,144,252

Employees: 82

Status: Active

Short Interest

Current Borrow Fee 0.65%

Range: 0.65% - 0.65%

Available Shares 5M

Range: 650K - 5.1M

Recent Changes

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime